Cargando…

Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT

OBJECTIVE: To confirm CXCL10 over production in bone marrow mesenchymal stem cells (MSCs) and circulating monocytes isolated from multiple sclerosis patients (MS) and identify predate cell molecular signature; to extend this analysis after autologous hematopoietic stem cell transplantation (AHSCT) t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonechi, Elena, Aldinucci, Alessandra, Mazzanti, Benedetta, di Gioia, Massimo, Repice, Anna Maria, Manuelli, Cinzia, Saccardi, Riccardo, Massacesi, Luca, Ballerini, Clara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241792/ https://www.ncbi.nlm.nih.gov/pubmed/25493279 http://dx.doi.org/10.1002/acn3.92

Ejemplares similares

The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies
por: Amoriello, Roberta, et al.
Publicado: (2020)

Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis
por: Amoriello, Roberta, et al.
Publicado: (2022)

Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT
por: Kvistad, Silje Agnethe Stokke, et al.
Publicado: (2022)

A non-traditional approach to cryopreservation by ultra-rapid cooling for human mesenchymal stem cells
por: Irdani, Tiziana, et al.
Publicado: (2019)

CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis
por: Aldinucci, Alessandra, et al.
Publicado: (2018)

Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity
por: Harris, Kristina M., et al.
Publicado: (2018)

Cytokine inflammatory threat, but not LPS one, shortens GABAergic synaptic currents in the mouse spinal cord organotypic cultures
por: Giacco, Vincenzo, et al.
Publicado: (2019)

Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis
por: Mariottini, Alice, et al.
Publicado: (2022)

TCR repertoire diversity in Multiple Sclerosis: High-dimensional bioinformatics analysis of sequences from brain, cerebrospinal fluid and peripheral blood
por: Amoriello, Roberta, et al.
Publicado: (2021)

Autologous haematopoietic stem cell transplantation versus low‐dose immunosuppression in secondary–progressive multiple sclerosis
por: Mariottini, Alice, et al.
Publicado: (2022)

Local injection of bone marrow progenitor cells for the treatment of anal sphincter injury: in-vitro expanded versus minimally-manipulated cells
por: Mazzanti, Benedetta, et al.
Publicado: (2016)

aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
por: Häußler, Vivien, et al.
Publicado: (2021)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi, Reihane, et al.
Publicado: (2021)

Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT
por: Boberg, Erik, et al.
Publicado: (2021)

Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)
por: Roberts, Fiona, et al.
Publicado: (2020)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
por: Bertolotto, Antonio, et al.
Publicado: (2020)

Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
por: Mariottini, Alice, et al.
Publicado: (2022)

Bridging pro-inflammatory signals, synaptic transmission and protection in spinal explants in vitro
por: Medelin, M., et al.
Publicado: (2018)

Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update
por: Mariottini, Alice, et al.
Publicado: (2023)

Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis
por: Helbig, Grzegorz, et al.
Publicado: (2017)

R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement
por: Steinhardt, Maximilian J., et al.
Publicado: (2021)

2737. Real World Evaluation of Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant (aHSCT) Patients, Is Routine Antifungal Prophylaxis Needed?
por: Perreault, Sarah, et al.
Publicado: (2023)

Unaffected in Cambodia
por: Marya, A.
Publicado: (2020)

3D Organotypic Spinal Cultures: Exploring Neuron and Neuroglia Responses Upon Prolonged Exposure to Graphene Oxide
por: Musto, Mattia, et al.
Publicado: (2019)

Monocytes secrete CXCL7 to promote breast cancer progression
por: Wang, Yi-Hsiang, et al.
Publicado: (2021)

CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis
por: Gouwy, Mieke, et al.
Publicado: (2016)

Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy
por: Clausi, Valeria, et al.
Publicado: (2015)

Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience()
por: Bertozzi, Andrea, et al.
Publicado: (2023)

The role of MSCs and CAR-MSCs in cellular immunotherapy
por: Yan, Lun, et al.
Publicado: (2023)

Immunomodulatory Effects of MSCs in Bone Healing
por: Medhat, Dalia, et al.
Publicado: (2019)

Hepatocyte growth factor mediates MSCs stimulated functional recovery in animal models of MS
por: Bai, Lianhua, et al.
Publicado: (2012)

Bone Marrow Mesenchymal Stromal Cells Stimulate Skeletal Myoblast Proliferation through the Paracrine Release of VEGF
por: Sassoli, Chiara, et al.
Publicado: (2012)

Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis
por: Mariottini, Alice, et al.
Publicado: (2022)

Dissecting the Pharmacodynamics and Pharmacokinetics of MSCs to Overcome Limitations in Their Clinical Translation
por: Salvadori, Michela, et al.
Publicado: (2019)

CXCL4 suppresses tolerogenic immune signature of monocyte‐derived dendritic cells
por: Silva‐Cardoso, Sandra C., et al.
Publicado: (2020)

Splenic differentiation and emergence of CCR5(+)CXCL9(+)CXCL10(+) monocyte-derived dendritic cells in the brain during cerebral malaria
por: Hirako, Isabella C., et al.
Publicado: (2016)

Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial
por: Massacesi, Luca, et al.
Publicado: (2014)

Exosomes from primed MSCs can educate monocytes as a cellular therapy for hematopoietic acute radiation syndrome
por: Forsberg, Matthew H., et al.
Publicado: (2021)

Detection is unaffected by the deployment of focal attention
por: Moher, Jeff, et al.
Publicado: (2013)

Blur Detection is Unaffected by Cognitive Load
por: Loschky, Lester C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b8ugqab716g211cdsoi8kvselv